Evidence map›Paper›PMID 37583754›Full record

ArticleSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society2023

The ameliorative effect of

Ibrahim Turan, Deniz Canbolat, Selim Demir, Gokcen Kerimoglu, Fatih Colak, Nihal Turkmen Alemdar, Ahmet Mentese, Yüksel Aliyazicioglu

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Ibrahim TuranDepartment of Biochemistry, Faculty of Pharmacy, University of Health Sciences, 06010, Ankara, Turkey.
Deniz CanbolatMedicinal Aromatic Plants Application and Research Center, Artvin Coruh University, 08000, Artvin, Turkey.
Selim DemirDepartment of Nutrition and Dietetics, Faculty of Health Sciences, Karadeniz Technical University, 61080, Trabzon, Turkey.
Gokcen KerimogluDepartment of Histology and Embryology, Faculty of Medicine, Karadeniz Technical University, 61080, Trabzon, Turkey.
Fatih ColakDepartment of Urology, Faculty of Medicine, Karadeniz Technical University, 61080, Trabzon, Turkey.
Nihal Turkmen AlemdarDepartment of Medical Services and Techniques, Vocational School of Health Services, Recep Tayyip Erdogan University, 53100, Rize, Turkey.
Ahmet MenteseDepartmant of Medical Biochemistry, Faculty of Medicine, Karadeniz Technical University, 61080, Trabzon, Turkey.
Yüksel AliyaziciogluDepartmant of Medical Biochemistry, Faculty of Medicine, Karadeniz Technical University, 61080, Trabzon, Turkey.
Karadeniz Technical University · TRArtvin Coruh University · TRRecep Tayyip Erdoğan University · TRSağlık Bilimleri Üniversitesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cisplatin (CDDP) is an important chemotherapeutic agent, accumulation of which in kidney tissue causes nephrotoxicity and renal failure. The aim of this study was to evaluate, for the first time in the literature, the protective effect of dimethyl sulfoxide (DMSO) extract of

Indexed as

ApoptosisCisplatinLC-MS-MSNephrotoxicityPrimula vulgaris

Identifiers

PMID37583754
PMCPMC10424254
OpenAlexW4385555096

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.